A Handa1, B Dickstein, N S Young, K E Brown. 1. Hematology Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD 20892, USA. handaa@nih.gov
Abstract
BACKGROUND: A novel nonenveloped single-stranded circular DNA virus (TTV) was recently identified. The prevalence of TTV in blood donors in the United States is, however, still unclear. STUDY DESIGN AND METHODS: Viral DNA was detected in US blood donors from five cities by using two sets of TTV primers: NG059/NG061/NG063 primers, which amplified the conserved region of strains 1 and 2, and T801/T935 primers, which amplified the 5' end region of the TTV sequence. A TTV antibody assay system was based on the detection of the truncated open reading frame (ORF)-1 (amino acids 1-411) from type 1b. The truncated ORF-1 was expressed as a fusion protein in Escherichia coli, and the fusion protein was used as the antigen in the antibody assay system. RESULTS: Viremia was detected in 21 (8. 4%) of 250 donors by use of NG059/NG061/NG063 primers and 104 (41. 6%) of 250 by use of T801/T935 primers. There was little correlation among the assays, which suggests the preferential detection of different strains with the different primers. TTV antibody was detected in 38 of 100 donors: 32 (84%) of 38 with concurrent TTV viremia and 6 (16%) of 38 without TTV viremia. TTV viremia and/or TTV antibody-positive samples were detected in 52 (52%) of 100 of US blood donors. CONCLUSION: Evidence of infection or exposure to TTV appears to be common among blood donors in United States.
BACKGROUND: A novel nonenveloped single-stranded circular DNA virus (TTV) was recently identified. The prevalence of TTV in blood donors in the United States is, however, still unclear. STUDY DESIGN AND METHODS: Viral DNA was detected in US blood donors from five cities by using two sets of TTV primers: NG059/NG061/NG063 primers, which amplified the conserved region of strains 1 and 2, and T801/T935 primers, which amplified the 5' end region of the TTV sequence. A TTV antibody assay system was based on the detection of the truncated open reading frame (ORF)-1 (amino acids 1-411) from type 1b. The truncated ORF-1 was expressed as a fusion protein in Escherichia coli, and the fusion protein was used as the antigen in the antibody assay system. RESULTS:Viremia was detected in 21 (8. 4%) of 250 donors by use of NG059/NG061/NG063 primers and 104 (41. 6%) of 250 by use of T801/T935 primers. There was little correlation among the assays, which suggests the preferential detection of different strains with the different primers. TTV antibody was detected in 38 of 100 donors: 32 (84%) of 38 with concurrent TTVviremia and 6 (16%) of 38 without TTVviremia. TTVviremia and/or TTV antibody-positive samples were detected in 52 (52%) of 100 of US blood donors. CONCLUSION: Evidence of infection or exposure to TTV appears to be common among blood donors in United States.
Authors: Charles C Chu; Lu Zhang; Arjun Dhayalan; Briana M Agagnina; Amanda R Magli; Gia Fraher; Sebastien Didier; Linda P Johnson; William J Kennedy; Rajendra N Damle; Xiao-Jie Yan; Piers E M Patten; Saul Teichberg; Prasad Koduru; Jonathan E Kolitz; Steven L Allen; Kanti R Rai; Nicholas Chiorazzi Journal: Mol Med Date: 2011-09-21 Impact factor: 6.354
Authors: Aaron Y Lee; Lakshmi Akileswaran; Michael D Tibbetts; Sunir J Garg; Russell N Van Gelder Journal: Ophthalmology Date: 2014-11-24 Impact factor: 12.079
Authors: Yao-Wei Huang; Kylie K Harrall; Barbara A Dryman; Tanja Opriessnig; Eric M Vaughn; Michael B Roof; Xiang-Jin Meng Journal: J Virol Date: 2012-07-18 Impact factor: 5.103
Authors: Sharon Chao Wootton; Dong Soon Kim; Yasuhiro Kondoh; Eunice Chen; Joyce S Lee; Jin Woo Song; Jin Won Huh; Hiroyuki Taniguchi; Charles Chiu; Homer Boushey; Lisa H Lancaster; Paul J Wolters; Joseph DeRisi; Don Ganem; Harold R Collard Journal: Am J Respir Crit Care Med Date: 2011-02-25 Impact factor: 21.405